138 related articles for article (PubMed ID: 36152755)
1. Quantitative comparison of blood vessel changes after treatment of retinopathy of prematurity with laser versus bevacizumab.
Wang W; Hong GJ; Stinnett SS; Freedman SF; Wallace DK; Prakalapakorn SG
J AAPOS; 2022 Dec; 26(6):323-326. PubMed ID: 36152755
[TBL] [Abstract][Full Text] [Related]
2. Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.
Erol N; Gürsoy H; Sahin A; Basmak H
J Pediatr Ophthalmol Strabismus; 2010 Aug; 47 Online():e1-4. PubMed ID: 21158371
[TBL] [Abstract][Full Text] [Related]
3. OUTCOMES OF NONCONFLUENT DIODE LASER PANRETINAL PHOTOCOAGULATION FOR AGGRESSIVE POSTERIOR RETINOPATHY OF PREMATURITY AFTER INTRAVITREAL BEVACIZUMAB.
Mammo DA; Rubino SM; Quiram PA
Retina; 2021 Apr; 41(4):706-710. PubMed ID: 32796444
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Clinical Outcomes of Intravitreal Bevacizumab Versus Laser Photocoagulation for ROP.
Moinul P; Nanji K; Barbosa J; Sarohia GS; Fung M; Isaza G; Chaudhary V
J Pediatr Ophthalmol Strabismus; 2024; 61(1):73-74. PubMed ID: 38306241
[No Abstract] [Full Text] [Related]
5. Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity.
Chung EJ; Kim JH; Ahn HS; Koh HJ
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1727-30. PubMed ID: 17690897
[TBL] [Abstract][Full Text] [Related]
6. Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity.
Vinekar A
Indian J Ophthalmol; 2021 Aug; 69(8):1988-1989. PubMed ID: 34304161
[No Abstract] [Full Text] [Related]
7. Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.
Kim J; Kim SJ; Chang YS; Park WS
Retina; 2014 Jan; 34(1):77-82. PubMed ID: 23807184
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity.
Hong GJ; Stinnett SS; Freedman SF; Wallace DK; Prakalapakorn SG
J AAPOS; 2021 Jun; 25(3):177-180. PubMed ID: 33964453
[TBL] [Abstract][Full Text] [Related]
9. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
[TBL] [Abstract][Full Text] [Related]
10. SHORT-TERM COMPUTER-ASSISTED QUANTIFICATION OF PLUS DISEASE AFTER TREATMENT OF TYPE 1 RETINOPATHY OF PREMATURITY WITH INTRAVITREAL BEVACIZUMAB OR RETINAL LASER PHOTOCOAGULATION.
Cabrera MT; Chia T; Wallace DK; Ulrich JN; Freedman SF; Ding L; Gertsch KR
Retin Cases Brief Rep; 2021 May; 15(3):314-319. PubMed ID: 30036271
[TBL] [Abstract][Full Text] [Related]
11. Late recurrence of retinopathy of prematurity after treatment with both intravitreal bevacizumab and laser.
Chen W; Binenbaum G; Karp K; Baumritter A; Pearson DJ; Maguire AM; Quinn GE
J AAPOS; 2014 Aug; 18(4):402-4. PubMed ID: 25087645
[TBL] [Abstract][Full Text] [Related]
12. Short-term retinal detachment risk after treatment of type 1 retinopathy of prematurity with laser photocoagulation versus intravitreal bevacizumab.
Barry GP; Tauber KA; Fisher M; Greenberg S; Zobal-Ratner J; Binenbaum G
J AAPOS; 2019 Oct; 23(5):260.e1-260.e4. PubMed ID: 31513902
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of retinopathy of prematurity six years after intravitreal injection of bevacizumab.
Yasin A; Sinha S; Smith R; Jain SF; Hejkal T; Rychwalski P
J AAPOS; 2023 Aug; 27(4):236-239. PubMed ID: 37451499
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage.
Nazari H; Modarres M; Parvaresh MM; Ghasemi Falavarjani K
Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1713-8. PubMed ID: 20582706
[TBL] [Abstract][Full Text] [Related]
15. Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.
Karaca C; Oner AO; Mirza E; Polat OA; Sahiner M
JAMA Ophthalmol; 2013 Aug; 131(8):1099-101. PubMed ID: 23744183
[No Abstract] [Full Text] [Related]
16. Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial.
Stahl A; Sukgen EA; Wu WC; Lepore D; Nakanishi H; Mazela J; Moshfeghi DM; Vitti R; Athanikar A; Chu K; Iveli P; Zhao F; Schmelter T; Leal S; Köfüncü E; Azuma N;
JAMA; 2022 Jul; 328(4):348-359. PubMed ID: 35881122
[TBL] [Abstract][Full Text] [Related]
17. Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels.
Lee JY; Chae JB; Yang SJ; Yoon YH; Kim JG
Graefes Arch Clin Exp Ophthalmol; 2010 Sep; 248(9):1257-62. PubMed ID: 20393741
[TBL] [Abstract][Full Text] [Related]
18. A rare case of aggressive posterior retinopathy of prematurity presenting with exudative retinal detachment.
Mittal K; Chawla R; Vukkadala T; Azad SV; Vohra R; Daga J
J AAPOS; 2021 Feb; 25(1):47-50. PubMed ID: 33144201
[TBL] [Abstract][Full Text] [Related]
19. Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9.
Laveti V; Balakrishnan D; Rani PK; Mohamed A; Jalali S
Int Ophthalmol; 2020 Dec; 40(12):3539-3545. PubMed ID: 32776299
[TBL] [Abstract][Full Text] [Related]
20. Comparison of 5-year safety and efficacy of laser photocoagulation and intravitreal bevacizumab injection in retinopathy of prematurity.
Murakami T; Sugiura Y; Okamoto F; Okamoto Y; Kato A; Hoshi S; Nagafuji M; Miyazono Y; Oshika T
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2849-2855. PubMed ID: 33744981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
